共 50 条
- [1] Istradefylline therapy for PD plus oromandibular dystoniaMOVEMENT DISORDERS, 2023, 38 : S635 - S635Kanzato, N. A. O.Mochizuki, S. A. T.
- [2] Parkinson's disease therapy with Istradefylline and blood biomarkers of epigeneticsNEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (05): : 276 - 283Kanzato, NaomiNakachi, KouNaka, TaroMochizuki, SatsukiMiyamae, YukaOkada, Yasunori
- [3] Istradefylline (Nourianz) for Parkinson's DiseaseMEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1591): : 20 - 23不详
- [4] Istradefylline for the treatment of Parkinson's diseaseEXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (01) : 111 - 114Park, ArianeStacy, Mark
- [5] The effect of istradefylline for anhedonia in Parkinson's diseaseMOVEMENT DISORDERS, 2015, 30 : S171 - S171Nagayama, H.Mishina, M.Kimura, K.
- [6] Istradefylline effects on L-Dopa resistant tremor in Parkinson's disease (PD)MOVEMENT DISORDERS, 2024, 39 : S333 - S333Ozay, G.Zhang, I.Umali, M.Lovelace, L.Barry, M.Serrano, L. ArizaSharma, A.Raslan, L.Torres-Yaghi, Y.Pagan, F.
- [7] The role of istradefylline in the Parkinson's disease armamentariumEXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (07) : 863 - 871Mueller, Thomas
- [8] The safety of istradefylline for the treatment of Parkinson's diseaseEXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 769 - 775Mueller, Thomas
- [9] Effect of Istradefylline on Motor and Non-motor Symptoms in Patients with Parkinson's disease (PD): the ISTRA ADJUST Parkinson's disease (PD) Randomized, Controlled StudyMOVEMENT DISORDERS, 2024, 39 : S307 - S307Nagayama, H.Hatano, T.Sengoku, R.Yanagisawa, N.Kano, O.